{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:19:56Z","timestamp":1780705196418,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15717-9","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:54:23Z","timestamp":1770969263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sesquiterpenoids target IFIT family proteins and LIMK1: potential implications for the tumor microenvironment and macrophage infiltration"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaobing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"15717_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal. A. Cancer statistics. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"15717_CR2","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2022;72:409\u201336.","journal-title":"CA Cancer J Clin"},{"key":"15717_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1056\/NEJMoa1413513","volume":"372","author":"SM Swain","year":"2023","unstructured":"Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med. 2023;372:724\u201334.","journal-title":"N Engl J Med"},{"key":"15717_CR4","doi-asserted-by":"crossref","first-page":"110998","DOI":"10.1016\/j.biopha.2020.110998","volume":"133","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang H, Xiang Y, Tian Q, Wang S. Development of targeted therapies for breast cancer: focus on HER2-positive breast cancer. Biomed Pharmacother. 2021;133:110998.","journal-title":"Biomed Pharmacother"},{"key":"15717_CR5","first-page":"650051","volume":"11","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Qiu P, Wang L, Zhu W. Immune checkpoint inhibitors in triple-negative breast cancer: A systematic review. Front Oncol. 2021;11:650051.","journal-title":"Front Oncol"},{"key":"15717_CR6","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1158\/1538-7445.AM2020-4569","volume":"80","author":"L Tan","year":"2020","unstructured":"Tan L, Wang J, Tanizaki J, Araki M, Michielin O. Recent advances in immunotherapy for cancer treatment. Cancer Res. 2020;80:4569\u201374.","journal-title":"Cancer Res"},{"key":"15717_CR7","first-page":"107430","volume":"38","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, et al. Discovery and resupply of Pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2021;38:107430.","journal-title":"Biotechnol Adv"},{"key":"15717_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 1981 to 2019. J Nat Prod. 2020;83:770\u2013803.","journal-title":"J Nat Prod"},{"key":"15717_CR9","first-page":"947","volume":"12","author":"MRG Kreuger","year":"2012","unstructured":"Kreuger MRG, Grootjans S, Biavatti MW, Vandenabeele P, D\u2019Herde K. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anticancer Agents Med Chem. 2012;12:947\u201362.","journal-title":"Anticancer Agents Med Chem"},{"key":"15717_CR10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","volume":"16","author":"E Le BideauF, Kellenberger","year":"2017","unstructured":"Le BideauF, Kellenberger E, Riedinger C. Marine natural products: another treasury for drug discovery. Nat Rev Drug Discov. 2017;16:531\u20132.","journal-title":"Nat Rev Drug Discov"},{"key":"15717_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.drudis.2010.06.002","volume":"15","author":"A Ghantous","year":"2010","unstructured":"Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today. 2010;15:668\u201378.","journal-title":"Drug Discov Today"},{"key":"15717_CR12","doi-asserted-by":"crossref","first-page":"112531","DOI":"10.1016\/j.biopha.2021.112531","volume":"146","author":"S Dhyani","year":"2022","unstructured":"Dhyani S, Tewari LM, Kumar A, Sesquiterpenes. A potential source of anti-cancer agents from Artemisia absinthium. Biomed Pharmacother. 2022;146:112531.","journal-title":"Biomed Pharmacother"},{"key":"15717_CR13","first-page":"1","volume":"36","author":"C Katiyar","year":"2022","unstructured":"Katiyar C, Gupta A, Kanjilal S, Katiyar S. Drug discovery from plant sources: an integrated approach. Nat Prod Res. 2022;36:1\u201316.","journal-title":"Nat Prod Res"},{"key":"15717_CR14","first-page":"104808","volume":"146","author":"R Maurya","year":"2021","unstructured":"Maurya R, Srivastava S, Maurya RK. Sesquiterpene lactones: natural sources, biological activities, and therapeutic potential. Fitoterapia. 2021;146:104808.","journal-title":"Fitoterapia"},{"key":"15717_CR15","first-page":"91","volume":"220","author":"T Pragna Lakshmi","year":"2018","unstructured":"Pragna Lakshmi T, Gokul Chander R, Nandhakumar E, Radhakrishnan R. Anticancer activity of Guaiacum sesquiterpene derivatives against triple-negative breast cancer via EGFR\/PI3K\/Akt pathway. J Ethnopharmacol. 2018;220:91\u2013100.","journal-title":"J Ethnopharmacol"},{"key":"15717_CR16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/molecules21080940","volume":"21","author":"SC Chiu","year":"2016","unstructured":"Chiu SC, Lai YY, Chen SP, Wang HC, Ho CT, Pan MH, et al. Sesquiterpene lactone isolated from antrodia cinnamomea inhibits the growth, migration, and invasion of human bladder cancer cells. Molecules. 2016;21:940.","journal-title":"Molecules"},{"key":"15717_CR17","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3892\/or.2017.5441","volume":"37","author":"J Liu","year":"2017","unstructured":"Liu J, Liu X, Peng J, Fang Z, Fang F, Wu J, et al. Sesquiterpene lactone parthenolide promotes autophagy and apoptosis in pancreatic cancer cells through ROS\/p53 signaling. Oncol Rep. 2017;37:2245\u201350.","journal-title":"Oncol Rep"},{"key":"15717_CR18","first-page":"345","volume":"19","author":"Z Que","year":"2017","unstructured":"Que Z, Liu Y, Tan Q, Yang D, Tian J, Lu H, et al. Dihydroartemisinin inhibits glioma aggressiveness through ROS to P53 to beta-catenin signaling. Neuro Oncol. 2017;19:345\u201355.","journal-title":"Neuro Oncol"},{"key":"15717_CR19","volume-title":"Pharmacopoeia of the people\u2019s Republic of China, part I","author":"National Pharmacopoeia Committee","year":"2020","unstructured":"National Pharmacopoeia Committee. Pharmacopoeia of the people\u2019s Republic of China, part I. Beijing, China: China Medical Science; 2020."},{"key":"15717_CR20","first-page":"114546","volume":"281","author":"L Mao","year":"2022","unstructured":"Mao L, Li J, Xiao X, Huang Z, Wang X, Zhang X, et al. Review on the Pharmacological and Pharmacokinetic properties of vladimiriae radix. J Ethnopharmacol. 2022;281:114546.","journal-title":"J Ethnopharmacol"},{"key":"15717_CR21","first-page":"98","volume":"45","author":"L Mao","year":"2018","unstructured":"Mao L, Huang Z, Zhang X, Chen H, Li J, Wang X. The medicinal impact of vladimiriae radix: A comprehensive review. Phytomedicine. 2018;45:98\u2013107.","journal-title":"Phytomedicine"},{"key":"15717_CR22","doi-asserted-by":"crossref","first-page":"112533","DOI":"10.1016\/j.jep.2019.112533","volume":"251","author":"S Mandal","year":"2020","unstructured":"Mandal S, Barik BB, Ghosh M, Ray A, Samanta A. Anti-inflammatory and analgesic effects of vladimiriae radix extract on experimental models. J Ethnopharmacol. 2020;251:112533.","journal-title":"J Ethnopharmacol"},{"key":"15717_CR23","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.3390\/molecules24193589","volume":"24","author":"L Mao","year":"2019","unstructured":"Mao L, Wang X, Huang Z, Zhang X, Li J, Chen H. Evaluation of the anticancer activity of vladimiriae radix and its extracts: A study based on in vitro and in vivo models. Molecules. 2019;24:3589.","journal-title":"Molecules"},{"key":"15717_CR24","first-page":"1372","volume":"19","author":"J Mao","year":"2019","unstructured":"Mao J, Yi M, Tao Y, Huang Y, Chen M. Costunolide isolated from Vladimiria souliei inhibits the proliferation and induces the apoptosis of HepG2 cells. Mol Med Rep. 2019;19:1372\u20139.","journal-title":"Mol Med Rep"},{"key":"15717_CR25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3389\/fphar.2018.01469","volume":"9","author":"J Mao","year":"2018","unstructured":"Mao J, Yi M, Wang R, Huang Y, Chen M. Protective effects of Costunolide against D-Galactosamine and Lipopolysaccharide-induced acute liver injury in mice. Front Pharmacol. 2018;9:1469.","journal-title":"Front Pharmacol"},{"key":"15717_CR26","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/ptr.7383","volume":"36","author":"J Mao","year":"2022","unstructured":"Mao J, Zhan H, Meng F, Wang G, Huang D, Liao Z, et al. Costunolide protects against alcohol-induced liver injury by regulating gut microbiota, oxidative stress and attenuating inflammation in vivo and in vitro. Phytother Res. 2022;36:1268\u201383.","journal-title":"Phytother Res"},{"key":"15717_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. affy\u2013Analysis of affymetrix genechip data at the probe level. Bioinform. 2004;20:307\u201315.","journal-title":"Bioinform"},{"key":"15717_CR28","unstructured":"Kilens S, Merkle FT, Williams LA, Inmaculada I-P, Brivanlou AH. Robustness and reproducibility of single-cell transcriptomics in human iPSC-derived neurons. PLoS ONE. 2018;13:e0191808."},{"key":"15717_CR29","doi-asserted-by":"crossref","unstructured":"Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics. 2011;12:35.","DOI":"10.1186\/1471-2105-12-35"},{"key":"15717_CR30","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"15717_CR31","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60\u20134.","journal-title":"Nucleic Acids Res"},{"key":"15717_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"15717_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"15717_CR34","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: Protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"15717_CR35","doi-asserted-by":"publisher","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","volume":"49","author":"SK Burley","year":"2021","unstructured":"Burley SK, RCSB Protein Data Bank. Biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology, and energy. Nucleic Acids Res. 2021;49:D437\u201351.","journal-title":"Nucleic Acids Res"},{"key":"15717_CR36","unstructured":"Xue W, Yang F, Wang P, Zheng G, Chen Y, Yao X. What contributes to the binding affinity and selectivity of novel checkpoint kinase 1 inhibitors? ChemMedChem. 2022;17:e202100541."},{"key":"15717_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonzalez-Blas CB, Moerman T, Imrichova H, Hulselmans G, Rambow F, et al. SCENIC: Single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083\u20136.","journal-title":"Nat Methods"},{"key":"15717_CR38","doi-asserted-by":"crossref","first-page":"lqaa026","DOI":"10.1093\/nargab\/lqaa026","volume":"2","author":"D Bhuva","year":"2020","unstructured":"Bhuva D, Cursons J, Davis M, Shapland C, Burge J, Bornot A, et al. Singscore: A scoring method for identifying gene signatures using single-sample RNA-Seq. NAR Genom Bioinform. 2020;2:lqaa026.","journal-title":"NAR Genom Bioinform"},{"key":"15717_CR39","first-page":"114852","volume":"285","author":"T Tian","year":"2023","unstructured":"Tian T, Yang Z, Zhang H, Yan H, Jiang H, Wang Z. ITCM: A pharmacotranscriptomics database of traditional Chinese medicine active ingredients. J Ethnopharmacol. 2023;285:114852.","journal-title":"J Ethnopharmacol"},{"key":"15717_CR40","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/14786419.2018.1489387","volume":"34","author":"T Abu-Izneid","year":"2020","unstructured":"Abu-Izneid T, Rauf A, Khalil AA, Olatunde A, Nadeem M, Mollah MH, et al. Sesquiterpenes and their derivatives: A review update. Nat Prod Res. 2020;34:2054\u201388.","journal-title":"Nat Prod Res"},{"key":"15717_CR41","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1128\/JVI.02744-14","volume":"89","author":"V Fensterl","year":"2015","unstructured":"Fensterl V, Sen GC. Interferon-Induced Ifit proteins: their role in viral pathogenesis. J Virol. 2015;89:2462\u20138.","journal-title":"J Virol"},{"key":"15717_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fmolb.2019.00148","volume":"6","author":"LS Pidugu","year":"2019","unstructured":"Pidugu LS, Pidugu VK, Wu MM, Liu CJ, Lee TC. Emerging functions of human IFIT proteins in cancer. Front Mol Biosci. 2019;6:148.","journal-title":"Front Mol Biosci"},{"key":"15717_CR43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fonc.2017.00304","volume":"7","author":"H Jia","year":"2017","unstructured":"Jia H, Zheng X, Zhang M, Guan T, Zhou Q, Wu X, et al. JAK1\/STAT1\/IFIT2 network functions as a potential prognostic indicator for colorectal cancer. Front Oncol. 2017;7:304.","journal-title":"Front Oncol"},{"key":"15717_CR44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fonc.2018.00480","volume":"8","author":"L Shen","year":"2018","unstructured":"Shen L, Gu L, Zhang Y, Dai J, Chen B, Wang S, et al. PLZF suppresses gallbladder cancer through transcriptionally increasing IFIT2 level. Front Oncol. 2018;8:480.","journal-title":"Front Oncol"},{"key":"15717_CR45","first-page":"115","volume":"192","author":"M Lai","year":"2022","unstructured":"Lai M, Liang P, Ma Y, Hao Y, Zhang Y, Liu Y, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-\u03b1 are involved in metastasis of IFIT2-depleted oral squamous cell carcinoma. Biochimie. 2022;192:115\u201324.","journal-title":"Biochimie"},{"key":"15717_CR46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12943-020-01233-2","volume":"19","author":"X Wang","year":"2020","unstructured":"Wang X, Zhang Y, Xiao H, Li Y, Yuan Q, Deng X, et al. IFIT3 confers chemotherapy resistance through regulating Post-Translational modifications of VDAC2 in pancreatic cancer. Mol Cancer. 2020;19:121.","journal-title":"Mol Cancer"},{"key":"15717_CR47","first-page":"6057","volume":"77","author":"M Yang","year":"2017","unstructured":"Yang M, Wang C, Luo W, Veena MS, Sharma S, Wang Q, et al. IFIT3 predicts the therapeutic response of IFN-\u03b1 in hepatocellular carcinoma patients. Cancer Res. 2017;77:6057\u201367.","journal-title":"Cancer Res"},{"key":"15717_CR48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fmolb.2018.00068","volume":"5","author":"AA Nushtaeva","year":"2018","unstructured":"Nushtaeva AA, Yurchenko MV, Zakharova MY, Zubtsov DA, Sokov DG, Krasilnikov MZ, et al. IFIT3 as a potential biomarker for the prognosis of breast cancer sensitivity to immune stimulation. Front Mol Biosci. 2018;5:68.","journal-title":"Front Mol Biosci"},{"key":"15717_CR49","first-page":"897601","volume":"9","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Zhang W, Wang L, Zhang X, Lin Y, Xie Z, et al. ISG20 correlates with immune infiltration and predicts poor survival in hepatocellular carcinoma. Front Mol Biosci. 2022;9:897601.","journal-title":"Front Mol Biosci"},{"key":"15717_CR50","doi-asserted-by":"crossref","unstructured":"Liu X, Song Q, Wang D, Liu Y, Zhang Z, Fu, W. LIMK1: a promising prognostic and immune infiltration indicator in colorectal cancer. Oncol Lett. 2022;24(1):234.","DOI":"10.3892\/ol.2022.13354"},{"key":"15717_CR51","first-page":"155737","volume":"150","author":"M Cao","year":"2022","unstructured":"Cao M, Luo L, Yin L, Wang L, Huang C, Zhang X, et al. HERC6 is Up-Regulated in peripheral blood mononuclear cells from patients with systemic lupus erythematosus and associated with disease progression. Cytokine. 2022;150:155737.","journal-title":"Cytokine"},{"key":"15717_CR52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2407-10-231","volume":"10","author":"S Sarma","year":"2010","unstructured":"Sarma S, Aherne S, Wang Z, Cao MY, Waisman DM, Luyt LG, et al. Suppression of IFIT2 expression in a human acute promyelocytic leukemia cell line decreases sensitivity to interferon \u03b1. BMC Cancer. 2010;10:231.","journal-title":"BMC Cancer"},{"key":"15717_CR53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13578-023-00980-1","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Yin H, Xie Q, Shi K, Cui X, Liu Y, et al. IFIH1 promotes M1 macrophage polarization through upregulating STAT1 expression. Cell Biosci. 2023;13:43.","journal-title":"Cell Biosci"},{"key":"15717_CR54","first-page":"39","volume":"69","author":"C Huang","year":"2018","unstructured":"Huang C, Hu Y, Yang Q, Gao L, Wang Y, Zhang S, et al. IFIT1\/2\/3 and MxA are upregulated in M1-Polarized human primary macrophages. Blood Cells Mol Dis. 2018;69:39\u201347.","journal-title":"Blood Cells Mol Dis"},{"key":"15717_CR55","doi-asserted-by":"crossref","first-page":"e004958","DOI":"10.1136\/jitc-2022-005132","volume":"10","author":"B Mallardo","year":"2022","unstructured":"Mallardo B, Maci G, Iorio V, Trotta AM, D\u2019Esposito V, Mori S, et al. Cetirizine enhances Anti-PD-1 efficacy in melanoma by promoting M1 macrophage polarization. J Immunother Cancer. 2022;10:e004958.","journal-title":"J Immunother Cancer"},{"key":"15717_CR56","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1038\/s41467-019-13410-z","volume":"10","author":"EA Irey","year":"2019","unstructured":"Irey EA, Lassiter CM, Brady AO, Chuntova P, Wang Y, Knutson KL, et al. JAK\/STAT Inhibition in macrophages promotes therapeutic resistance by inducing expression of Co-Stimulatory molecule CD40. Nat Commun. 2019;10:5552.","journal-title":"Nat Commun"},{"key":"15717_CR57","first-page":"3666","volume":"113","author":"Y Wu","year":"2022","unstructured":"Wu Y, Fang Z, Liu H, Yang C, Sun Y, Wang X, et al. CXCL9 overexpression linked to M1 macrophage accumulation predicts a favorable prognosis in Triple-Negative breast cancer. Cancer Sci. 2022;113:3666\u201377.","journal-title":"Cancer Sci"},{"key":"15717_CR58","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.tibtech.2018.04.004","volume":"36","author":"M Farokhi","year":"2018","unstructured":"Farokhi M, Mottaghitalab F, Fatahi Y, Khademhosseini A, Kaplan DL. Overview of silk fibroin use in wound dressings. Trends Biotechnol. 2018;36:907\u201322.","journal-title":"Trends Biotechnol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15717-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:02:52Z","timestamp":1774285372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15717"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15717-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"376"}}